WA
DPLO

WFG Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

WFG Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-450
Closed -$13K – 1799
2016
Q3 		$13K Buy
+450
New +$15.1K ﹤0.01% 1062

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WFG Advisors's DPLO Position: Q4 2016 in Review

WFG Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2016, closing a stake of 450 shares — an estimated $13K sold.

WFG Advisors first reported a position in DPLO in Q3 2016 and held it in 1 quarter. The position peaked at $13K in Q3 2016. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

  • WFG Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2016 after selling out during the quarter.
  • WFG Advisors sold 450 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $13K.
  • WFG Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2016 and held it in 1 quarter.
  • WFG Advisors's DIPLOMAT PHARMACY, INC. position peaked at $13K in Q3 2016.
  • 174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on WFG Advisors's 13F filing for Q4 2016, filed 1 Mar 2017.